Patent · US Active

Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space

US10888505B2 · kind B2 · utility

23Cited by
110References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 20, 2017
Grant dateJan 12, 2021
Priority date
Expiry dateOct 20, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2800/87
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein is a dosage of foam including from about 7.5 cm3 to about 70 cm3. The foam includes from about 0.5 g to about 4 g of a detersive surfactant; from about 0.001 g to about 4 g propellant; a foam density of from about 0.05 g/cm3 to about 0.35 g/cm3; a bubble size distribution having an R32 of from about 5 μm to about 100 μm; from about 0.001 g to about 2.45 g of a scalp health agent; a β value of from about 0.0075 g/cm3 to about 0.1575 g/cm3; and a β′ value of from about 0.00005 g/cm3 to about 0.035 g/cm3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.